Literature DB >> 24840316

The microbiota, the immune system and the allograft.

M-L Alegre1, R B Mannon, P J Mannon.   

Abstract

The microbiota represents the complex collections of microbial communities that colonize a host. In health, the microbiota is essential for metabolism, protection against pathogens and maturation of the immune system. In return, the immune system determines the composition of the microbiota. Altered microbial composition (dysbiosis) has been correlated with a number of diseases in humans. The tight reciprocal immune/microbial interactions complicate determining whether dysbiosis is a cause and/or a consequence of immune dysregulation and disease initiation or progression. However, a number of studies in germ-free and antibiotic-treated animal models support causal roles for intestinal bacteria in disease susceptibility. The role of the microbiota in transplant recipients is only starting to be investigated and its study is further complicated by putative contributions of both recipient and donor microbiota. Moreover, both flora may be affected directly or indirectly by immunosuppressive drugs and antimicrobial prophylaxis taken by transplant patients, as well as by inflammatory processes secondary to ischemia/reperfusion and allorecognition, and the underlying cause of end-organ failure. Whether the ensuing dysbiosis affects alloresponses and whether therapies aimed at correcting dysbiosis should be considered in transplant patients constitutes an exciting new field of research. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Acute rejection; alloimmunity; chronic rejection; microbiota; pattern-recognition receptor

Mesh:

Year:  2014        PMID: 24840316      PMCID: PMC4423796          DOI: 10.1111/ajt.12760

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  116 in total

1.  The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut.

Authors:  Shimpei Kawamoto; Thinh H Tran; Mikako Maruya; Keiichiro Suzuki; Yasuko Doi; Yumi Tsutsui; Lucia M Kato; Sidonia Fagarasan
Journal:  Science       Date:  2012-04-27       Impact factor: 47.728

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

3.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis.

Authors:  Djahida Bouskra; Christophe Brézillon; Marion Bérard; Catherine Werts; Rosa Varona; Ivo Gomperts Boneca; Gérard Eberl
Journal:  Nature       Date:  2008-11-05       Impact factor: 49.962

5.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

6.  Lymphotoxin regulates commensal responses to enable diet-induced obesity.

Authors:  Vaibhav Upadhyay; Valeriy Poroyko; Tae-jin Kim; Suzanne Devkota; Sherry Fu; Donald Liu; Alexei V Tumanov; Ekaterina P Koroleva; Liufu Deng; Cathryn Nagler; Eugene B Chang; Hong Tang; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

Review 7.  The gut microbiota and obesity: from correlation to causality.

Authors:  Liping Zhao
Journal:  Nat Rev Microbiol       Date:  2013-08-05       Impact factor: 60.633

8.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  Gut microbiomes of Malawian twin pairs discordant for kwashiorkor.

Authors:  Michelle I Smith; Tanya Yatsunenko; Mark J Manary; Indi Trehan; Rajhab Mkakosya; Jiye Cheng; Andrew L Kau; Stephen S Rich; Patrick Concannon; Josyf C Mychaleckyj; Jie Liu; Eric Houpt; Jia V Li; Elaine Holmes; Jeremy Nicholson; Dan Knights; Luke K Ursell; Rob Knight; Jeffrey I Gordon
Journal:  Science       Date:  2013-01-30       Impact factor: 47.728

View more
  21 in total

Review 1.  Impact of environmental factors on alloimmunity and transplant fate.

Authors:  Leonardo V Riella; Jessamyn Bagley; John Iacomini; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

Review 2.  Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.

Authors:  Wei Pan; Yongbo Kang
Journal:  Int Urol Nephrol       Date:  2017-08-28       Impact factor: 2.370

Review 3.  Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses.

Authors:  B M Matta; D K Reichenbach; B R Blazar; H R Turnquist
Journal:  Am J Transplant       Date:  2016-07-12       Impact factor: 8.086

4.  Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.

Authors:  B D Modena; R Milam; F Harrison; J A Cheeseman; M M Abecassis; J J Friedewald; A D Kirk; D R Salomon
Journal:  Am J Transplant       Date:  2016-10-11       Impact factor: 8.086

Review 5.  The concept of gut rehabilitation and the future of visceral transplantation.

Authors:  Kareem Abu-Elmagd
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-20       Impact factor: 46.802

6.  Codominant Role of Interferon-γ- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients.

Authors:  T J Borges; J T O'Malley; L Wo; N Murakami; B Smith; J Azzi; S Tripathi; J D Lane; E M Bueno; R A Clark; S G Tullius; A Chandraker; C G Lian; G F Murphy; T B Strom; B Pomahac; N Najafian; L V Riella
Journal:  Am J Transplant       Date:  2016-04-07       Impact factor: 8.086

7.  High-Fat Diet-Induced Obesity Enhances Allograft Rejection.

Authors:  Luciana L Molinero; Dengping Yin; Yuk Man Lei; Luqiu Chen; Ying Wang; Anita S Chong; Maria-Luisa Alegre
Journal:  Transplantation       Date:  2016-05       Impact factor: 4.939

Review 8.  An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients.

Authors:  O C Smibert; M A Paraskeva; G Westall; Greg Snell
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

9.  Berberine Promotes Induction of Immunological Tolerance to an Allograft via Downregulating Memory CD8+ T-Cells Through Altering the Gut Microbiota.

Authors:  Feifei Qiu; Weihui Lu; Shulin Ye; Huazhen Liu; Qiaohuang Zeng; Haiding Huang; Chun-Ling Liang; Yuchao Chen; Fang Zheng; Qunfang Zhang; Chuan-Jian Lu; Zhenhua Dai
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

Review 10.  Myeloid and Mesenchymal Stem Cell Therapies for Solid Organ Transplant Tolerance.

Authors:  Jennifer Li; Angus W Thomson; Natasha M Rogers
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 5.385

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.